Since 2009, I joined the National Center for Genetic Engineering and Biotechnology (BIOTEC, NSTDA), Thailand, there, I was given the opportunity to learn the deep ends of scientific research, to which am now dedicated. My research group focuses on development of antimalarial drug. My major research interest is on the generation of transgenic Plasmodium berghei as models for drug screening in animals. I was also involved in the construction of transfection of the plasmids into P. berghei by using the CRISPR/Cas9 system. Over the years I have been saddled with the core responsibilities of developing and managing the in vivo components of compound testing towards the discovery of novel antimalarial compounds by the group. I also played supporting roles in every project in the lab that uses animal laboratory technique such as pharmacokinetic study of novel antimalarial compounds. In 2019, I decided to undertake the Ph.D. program in veterinary science, Faculty of Veterinary Medicine, Chiang Mai University, which is renowned and reputable in animal health innovation. I graduated Ph.D. program in 2022 and work as a proactive researcher at Chiang Mai University. I hope any knowledge from my research will benefit animal health and veterinary science.